Barclays
FBLG icon

Barclays’s FibroBiologics FBLG Stock Holding History

Barclays’s Portfolio FBLG Stock Details FBLG Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$6.86K Buy
+7,243
New +$8.41K ﹤0.01% 4746
2026
Q1 		– Hold
0
– – – 5515
2025
Q4 		– Hold
0
– – – 5771
2025
Q3 		– Hold
0
– – – 5454
2025
Q2 		– Sell
-1,486
Closed -$26.8K – 5207
2025
Q1 		$26.7K Sell
1,486
-679
-31% -$19.4K ﹤0.01% 4747
2024
Q4 		$86.6K Buy
2,165
+167
+8% +$8.96K ﹤0.01% 4629
2024
Q3 		$123K Buy
1,998
+1,567
+364% +$104K ﹤0.01% 4514
2024
Q2 		$43K Buy
+431
New +$82.2K ﹤0.01% 4261

Other funds holding FBLG

CFP
Cascade Financial Partners San Diego, California $1.15B AUM 33.6% 1-Year Est. Return
FEG
Fund Evaluation Group Cincinnati, Ohio $3.7B AUM 16.56% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Qube Research & Technologies (QRT)
Qube Research & Technologies (QRT) London, United Kingdom $108B AUM 37.29% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Fiduciary Trust
Vanguard Fiduciary Trust Malvern, Pennsylvania $454B AUM
TRCT
Tower Research Capital (TRC) New York $4.08B AUM 58.77% 1-Year Est. Return
Osaic Holdings
Osaic Holdings Scottsdale, Arizona $85.1B AUM 27.35% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $786B AUM 40.34% 1-Year Est. Return

Barclays's FBLG Position: Q2 2026 in Review

Barclays opened a new position in FibroBiologics (FBLG) in Q2 2026: 7,243 shares worth $6.86K. The stake represents ﹤0.01% of the portfolio and ranks #4746 among its holdings. This is a return to the name: Barclays previously reported a position in FBLG as recently as Q1 2025.

Barclays first reported a position in FBLG in Q2 2024 and has held it in 5 quarters since. The position peaked at $123K in Q3 2024. 16 funds tracked by Wall St. Rank hold FBLG as of Q2 2026.

  • Barclays held 7,243 shares of FibroBiologics worth $6.86K as of Q2 2026.
  • FibroBiologics was a new Barclays position in Q2 2026.
  • FibroBiologics made up ﹤0.01% of Barclays's portfolio in Q2 2026, its #4746 holding.
  • Barclays first reported a position in FibroBiologics in Q2 2024 and has held it in 5 quarters since.
  • Barclays's FibroBiologics position peaked at $123K in Q3 2024.
  • 16 funds tracked by Wall St. Rank held FibroBiologics as of Q2 2026.

Based on Barclays's 13F filing for Q2 2026, filed 14 Aug 2026.